
Transactions: Share issues and placements
Filter


New share issue in Axis Shield (UK/NO) — NOK 130 million

Secondary placing of 1.45 million shares in Orexo (SE) — SEK 175 million

Rights issue in Karo Bio (SE) — SEK 325 million

Secondary offering of shares in Vestas (DK) — DKK 413 million

Directed new share issue in Noreco (NO) — NOK 1.2 billion
Secondary offering of shares in Nordea (SE) — SEK 4.6 billion
Secondary placing of 260 million shares in Nordea Bank AB (SE) — SEK 19.5 billion

Initial public offering of M&E Biotech A/S (DK) — DKK 375 million

Rights issue in Medivir (SE) — SEK 225 million

Directed new share issue in Active Biotech (SE) — SEK 375 million
